Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA)

Behavioural Brain Research

Volumn 158, Issue 2, 2005, Pages 191-199

  Hemsley, Kim M ^a,b   Hopwood, John J ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Gait; Gender; Geotaxis; Grip strength; Locomotion; Motor; Mouse; MPS IIIA

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN REGION; CATALEPSY; CHRONOLOGY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GAIT; GRIP STRENGTH; LOCOMOTION; LYSOSOME STORAGE DISEASE; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROMUSCULAR SYSTEM; NEUROPATHOLOGY; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; SANFILIPPO SYNDROME;

EID: 13444287759     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2004.08.019     Document Type: Article

References (33)

1. C. Behl, M. Widmann, T. Trapp, and F. Holsboer 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro Biochem Biophys Res Commun 216 1995 473 482
2. R. Bhattacharyya, B. Gliddon, T. Beccari, J.J. Hopwood, and P. Stanley A novel missense mutation in lysosomal sulfamidase is the basis of MPS IIIA in a spontaneous mouse mutant Glycobiology 11 2001 99 103
3. M. Bhaumik, V.J. Muller, T. Rozaklis, L. Johnson, K. Dobrenis, and R. Bhattacharyya A mouse model for mucopolysaccharidosis type IIIA (Sanfilippo syndrome) Glycobiology 9 1999 1389 1396
4. V.J. Bolivar, K. Manley, and A. Messer Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice Brain Res 1005 2004 29 35
5. S. Chiavegatto, J. Sun, R.J. Nelson, and R.L. Schnaar A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice Exp Neurol 166 2000 227 234
6. K.A. Clarke, and J. Still Gait analysis in the mouse Physiol Behav 66 1999 723 729
7. M.A. Cleary, and J.E. Wraith Management of mucopolysaccharidosis type III Arch Dis Child 69 1993 403 406
8. B. Costall, and R.J. Naylor The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents Neuropharmacology 13 1974 353 364
9. J.N. Crawley Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests Brain Res 835 1999 18 26
10. J.N. Crawley What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice 2000 Wiley-Liss New York
11. A.D. Crocker, and K.M. Hemsley An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy Prog Neuropsychopharmacol Biol Psychiatry 25 2001 573 590
12. G. Ebersbach, M. Sojer, F. Vallodeoriola, J. Wissel, J. Muller, and E. Tolosa Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy Brain 122 1999 1349 1355
13. P.O. Fernagut, E. Diguet, B. Labattu, and F. Tison A simple method to measure stride length as an index of nirostriatal dysfunctionin mice J Neurosci Methods 113 2002 123 130
14. O. Gabrielli, G. Polonara, L. Regnicolo, V. Petroni, T. Scarabino, and G.V. Coppa Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses Am J Med Gen 125A 2004 224 231
15. B.L. Gliddon, and J.J. Hopwood Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice Pediatr Res 56 2004 65 72
16. Cressent A, Desmaris N, Verot L, Vanier MT, Heard JM. Gene therapy for Sanfilippo disease: trials in mucopolysaccharidosis type IIIB mice. In: Proceedings of the 8th International Symposium on Mucopolysaccharide and Related Diseases, Mainz, Germany, 2004.
17. M. Jeyakumar, T.D. Butters, M. Cortina-Borja, V. Hunnam, R.L. Proia, and V.H. Perry Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin Proc Natl Acad Sci USA 96 1999 6388 6393
18. M.Z. Jones, J. Alroy, P.J. Boyer, K.T. Cavanagh, K. Johnson, and D. Gage Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics J Neuropathol Exp Neurol 57 1997 148 157
19. W.C. Koller, and J. Trimble The gait abnormality of Huntington's disease Neurology 35 1985 1450 1454
20. J.C. Kreider, and M.S. Blumberg Geotaxis in 2-week-old Norway rats (Rattus norvegicus): a re-evaluation Dev Psychobiol 35 1999 35 42
21. H.H. Li, W.H. Yu, N. Rozengurt, H.Z. Zhao, K.M. Lyons, and S. Anagnostaras Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase Proc Natl Acad Sci USA 96 1999 14505 14510
22. D.B. McGavern, L. Zoecklein, S. Sathornsumetee, and M. Rodriguez Assessment of hindlimb gait as a powerful indicator of axonal loss in a murine model of progressive CNS demyelination Brain Res 877 2000 396 400
23. L.B. Menalled, J.D. Sison, I. Dragatsis, S. Zeitlin, and M.F. Chesselet Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats J Comp Neurol 465 2003 11 26
24. P.J. Meikle, J.J. Hopwood, A.E. Clague, and W.F. Carey Prevalence of lysosomal storage disorders J Am Med Assoc 281 1999 249 254
25. P.D. Murray, D.B. McGavern, S. Sathornsumetee, and M. Rodriguez Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis Brain 124 2001 1403 1416
26. E.F. Neufeld, and J. Muenzer The mucopolysaccharidoses C.R. Scriver A.L. Beaudet W.S. Sly D. Valle Metabolic basis of inherited disease, 7th ed 1995 McGraw-Hill New York 245 2494
27. T. Ogata, Y. Nakamura, K. Tsuji, T. Shibata, and K. Kataoka Steroid hormones protect spinal cord neurons from glutamate toxicity Neuroscience 55 1993 445 449
28. P.S. Savas, K.M. Hemsley, and J.J. Hopwood Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA Mol Genet Metab 82 2004 273 285
29. H. Steinberg, E.A. Sykes, A. McBride, P. Terry, K. Robinson, and H. Tillotson Computer analysis, using a digitizer of ataxic mouse gait due to drugs J Pharmacol Methods 21 1989 103 113
30. H. Vedder, N. Anthes, G. Stumm, C. Wurz, C. Behl, and J.-C. Krieg Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system J Neurochem 72 1999 2531 2538
31. V. Voikar, H. Rauvala, and E. Ikonen Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease Behav Brain Res 132 2002 1 10
32. C.S. Woolley, and B.S. McEwan Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat J Comp Neurol 33 1993 293 306
33. D.I. Zafeiriou, P.A. Savvopoulou-Augoustidou, A. Sewell, F. Papadopoulou, M. Badouraki, and E. Vargiami Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B) Brain Dev 23 2001 385 389